Table 1.

Clinical characteristics of the study participants

n	72
Age (years)	46.2 ± 1.8
Sex (male/female)	39/33
BMI (kg/m2)	29.9 ± 1.2
Fasting plasma glucose (mg/dL)	111 ± 2
2 h glucose (mg/dL)	208 ± 9
Basal insulin (μU/mL)	14.0 ± 1.2
Insulinogenic index [(μU/mL)/(mg/dL)]	0.77 ± 0.10
HOMA-IR	3.8 ± 0.3
Matsuda index	2.8 ± 0.2
Hepatic insulin resistance index × 106	5.9 ± 0.5
HbA1c (%)	6.8 ± 0.2
Total cholesterol (mg/dL)	200 ± 4
Triglycerides (mg/mL)	140 ± 9
HDL cholesterol (mg/mL)	46 ± 1
Aspartate aminotransferase (IU/L)	44 ± 3
Alanine aminotransferase (IU/L)	72 ± 7
Historogical scores
Stage (0/1/2/3/4)	2/17/20/7/6
Grade (0/1/2/3)	37/16/14/5
Steatosis (0/1/2/3)	0/31/23/18
Statin (+/−)	17/55
Angiotensin receptor blocker (+/−)	13/59
Insulin (+/−)	17/55

BMI, body mass index; HbA1c, hemoglobin A1c; HDL cholesterol, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance. Data are presented as mean ± standard error of the mean or absolute numbers.